Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial.
第一作者机构:[1]Sun Yat Sen Univ, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med, Ctr Canc,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China[2]Guangzhou Med Univ, Canc Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China[3]Jiangxi Canc Hosp, Dept Radiat Oncol, Nanchang, Jiangxi, Peoples R China[4]First Peoples Hosp Foshan, Dept Radiat Oncol, Foshan, Peoples R China[5]Fourth Mil Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian, Shaanxi, Peoples R China[6]Huazhong Univ Sci & Technol, Tongji Hosp, Wuhan, Hubei, Peoples R China[7]Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China[8]Hangzhou Canc Hosp, Hangzhou, Zhejiang, Peoples R China[9]Guangxi Zhuang Autonomous Reg, Peoples Hosp, Dept Radiat Oncol, Nanning, Peoples R China[10]Wuhan Univ, Zhongnan Hosp, Renmin Hosp, Wuhan, Hubei, Peoples R China
推荐引用方式(GB/T 7714):
Zhao Chong,Miao Jingjing,Shen Guanzhu,et al.Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial.[J].JOURNAL OF CLINICAL ONCOLOGY.2017,35:-.doi:10.1200/JCO.2017.35.15_suppl.6028.
APA:
Zhao, Chong,Miao, Jingjing,Shen, Guanzhu,Li, Jin-Gao,Zhang, Ning...&Xie, Conghua.(2017).Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial..JOURNAL OF CLINICAL ONCOLOGY,35,
MLA:
Zhao, Chong,et al."Nimotuzumab combined with cisplatin plus fluorouracil chemotherapy in patients with metastatic nasopharyngeal carcinoma after radical radiotherapy: A multicentre, open-label, phase II clinical trial.".JOURNAL OF CLINICAL ONCOLOGY 35.(2017):-